British drugmaker GSK said on Tuesday its experimental therapy, linerixibat, met its main goal in a late-stage trial to treat ...

Diabetes mellitus is a common, chronic metabolic disease that affects a variety of organs including the skin, the largest organ in the body. Between 30 and 70 percent of people ...